Cancer antigen 125 levels in inflammatory bowel diseases

Hilmi Ataseven ¹, Zeynel Abidin Oztürk , Mehmet Arhan , Osman Yüksel , Seyfettin Köklü , Mehmet Ibiş , Omer Başar , Fatma Meriç Yilmaz , Ilhami Yüksel

Affiliations

¹ Department of Gastroenterology, Erzurum Bölge Egitim ve Araştirma Hastanesi, Erzurum, Turkey.

PMID: 19623645
31 References
5 citations

Abstract

Background: Cancer antigen 125 (CA-125) is a tumor marker used for the diagnosis and monitoring of ovarian carcinoma. It can also be elevated in endometriosis, inflammations, and in nongynecological malignancies. Up to date, serum CA-125 levels in inflammatory bowel diseases (IBD) have not been studied before.

Aim: To assess the levels of CA-125 in patients with ulcerative colitis (UC) and Crohn's disease (CD).

Methods: Serum levels of CA-125 were investigated in 68 cases with UC (male/female: 47/21), 32 CD (male/female: 21/11), and 31 healthy controls (male/female: 16/15). Levels of CA-125 were also compared among UC patients according to lesion location, severity, and activity of CD.

Results: Serum CA-125 levels were 17.29+/-24.50 U/ml, 15.56+/-20.74 U/ml, and 8.85+/-2.62 U/ml in patients with UC, CD, and healthy controls, respectively. Serum CA-125 levels were significantly higher in UC compared to control group (P=0.001). Serum CA-125 levels were higher in CD patients compared to control group but there was no significance (P=0.087). Serum CA-125 levels were higher in pancolitis compared to distal type and left-sided UC.

Conclusions: Our data suggest that serum CA-125 levels may be increased in patients with IBDs.

Other Links

Free PMC article
Full text on Journal of clinical laboratory analysis

References
Cited By

References
Immune dysfunction in inflammatory bowel disease. Manuela G Neuman. Transl Res, 2007 Mar 27; 149(4). PMID: 17383591 Review.
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. W R Best, J M Becktel, J W Singleton, F Kern. Gastroenterology, 1976 Mar 11; 70(3). PMID: 1248701 Highly Cited.
Current and future diagnostic approaches: from serologies to imaging. David H Bruining, Edward V Loftus. Curr Gastroenterol Rep, 2008 Apr 02; 9(6). PMID: 18377802 Review.
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. A G Røseth, E Aadland, K Grzyb. Scand J Gastroenterol, 2004 Oct 30; 39(10). PMID: 15513345
New concepts in the pathophysiology of inflammatory bowel disease. Giorgos Bamias, Mark R Nyce, +3 authors, American Physiological Society. less Ann Intern Med, 2005 Dec 21; 143(12). PMID: 16365470 Review.
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. A Bitton, M A Peppercorn, +8 authors, A C Stevens. less Gastroenterology, 2001 Feb 24; 120(1). PMID: 11208709
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Sunanda V Kane, William J Sandborn, +5 authors, Stephen B Hanauer. less Am J Gastroenterol, 2003 Jun 24; 98(6). PMID: 12818275
Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea. K D Fine, F Ogunji, +2 authors, J George, M D Niehaus, R L Guerrant. less Am J Gastroenterol, 1998 Aug 26; 93(8). PMID: 9707055
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Craig A Solem, Edward V Loftus, +3 authors, William J Sandborn. less Inflamm Bowel Dis, 2005 Jul 27; 11(8). PMID: 16043984 Highly Cited.
Review article: Crohn's disease: monitoring disease activity. R Sostegni, M Daperno, +3 authors, N Scaglione, A Lavagna, R Rocca, A Pera. less Aliment Pharmacol Ther, 2003 Jun 06; 17 Suppl 2. PMID: 12786607 Review.
Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. I E Koutroubakis, E Petinaki, +5 authors, E A Kouroumalis. less Am J Gastroenterol, 2001 Mar 10; 96(2). PMID: 11232689
Laboratory markers in IBD: useful, magic, or unnecessary toys? S Vermeire, G Van Assche, P Rutgeerts. Gut, 2006 Feb 14; 55(3). PMID: 16474109 Free PMC article. Highly Cited. Review.
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. M Peeters, S Joossens, +3 authors, S Vermeire, R Vlietinck, X Bossuyt, P Rutgeerts. less Am J Gastroenterol, 2001 Mar 31; 96(3). PMID: 11280542
Cancer antigen 125 associated with multiple benign and malignant pathologies. C Miralles, M Orea, +7 authors, T Gea. less Ann Surg Oncol, 2003 Mar 07; 10(2). PMID: 12620910
Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. R Guimbaud, V Bertrand, +5 authors, S Chaussade. less Am J Gastroenterol, 1998 Dec 22; 93(12). PMID: 9860399
CA125 production by the peritoneum: in-vitro and in-vivo studies. M Epiney, C Bertossa, +2 authors, A Weil, A Campana, P Bischof. less Hum Reprod, 2000 Jun 01; 15(6). PMID: 10831552
Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Philippe Goyette, Catherine Labbé, +2 authors, Truc T Trinh, Ramnik J Xavier, John D Rioux. less Ann Med, 2007 Apr 26; 39(3). PMID: 17457716 Review.
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. R C Bast, T L Klug, +9 authors, R C Knapp. less N Engl J Med, 1983 Oct 13; 309(15). PMID: 6310399 Highly Cited.
Serum carbohydrate antigen 125 levels in advanced heart failure: relation to B-type natriuretic peptide and left atrial volume. Dursun Duman, Fatih Palit, Ergun Simsek, Karadag Bilgehan. Eur J Heart Fail, 2008 May 27; 10(6). PMID: 18501671
Cancer antigen 125 and prognosis. Estrid Høgdall. Curr Opin Obstet Gynecol, 2008 Jan 17; 20(1). PMID: 18196998 Review.
Cortisone in ulcerative colitis; final report on a therapeutic trial. S C TRUELOVE, L J WITTS. Br Med J, 1955 Oct 29; 2(4947). PMID: 13260656 Free PMC article. Highly Cited.
Recent understanding of IBD pathogenesis: implications for future therapies. Torsten Kucharzik, Christian Maaser, +4 authors, Wolfram Domschke. less Inflamm Bowel Dis, 2006 Nov 01; 12(11). PMID: 17075348 Review.
CA 125 secretion by peritoneal mesothelial cells. A M Zeillemaker, H A Verbrugh, A A Hoynck van Papendrecht, P Leguit. J Clin Pathol, 1994 Mar 01; 47(3). PMID: 8163699 Free PMC article.
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. W J Sandborn, E V Loftus, +11 authors, S R Targan. less Inflamm Bowel Dis, 2001 Aug 23; 7(3). PMID: 11515844
Review of fecal biomarkers in inflammatory bowel disease. Andrew D Sutherland, Richard B Gearry, Frank A Frizelle. Dis Colon Rectum, 2008 Jun 11; 51(8). PMID: 18543035 Review.
New players in the cytokine orchestra of inflammatory bowel disease. Massimo C Fantini, Giovanni Monteleone, Thomas T Macdonald. Inflamm Bowel Dis, 2007 Aug 23; 13(11). PMID: 17712836 Review.
The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Nikos T Kouris, Ioannis D Zacharos, +5 authors, Dimitris K Babalis. less Eur J Heart Fail, 2005 Feb 11; 7(2). PMID: 15701467
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. D Rachmilewitz. BMJ, 1989 Jan 14; 298(6666). PMID: 2563951 Free PMC article. Highly Cited.
CA125: megadaltons of novel opportunities. Oliver Dorigo, Jonathan S Berek. Gynecol Oncol, 2007 Feb 20; 104(3). PMID: 17306691
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Jost Langhorst, Sigrid Elsenbruch, +3 authors, Gustav J Dobos. less Am J Gastroenterol, 2007 Oct 06; 103(1). PMID: 17916108 Highly Cited.
Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. C G B Peterson, P Sangfelt, +3 authors, M Wagner, T Hansson, H Lettesjö, M Carlson. less Scand J Clin Lab Invest, 2007 Nov 24; 67(8). PMID: 18034391

Citedby
Correlates of the preoperative level of CA125 at presentation of ovarian cancer. Daniel W Cramer, Allison F Vitonis, +4 authors, Ross S Berkowitz. less Gynecol Oncol, 2010 Sep 21; 119(3). PMID: 20850174 Free PMC article.
Clinical laboratory and imaging evidence for effectiveness of agarose-agarose macrobeads containing stem-like cells derived from a mouse renal adenocarcinoma cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer: Evaluation of a biological-systems approach to cancer therapy (U.S. FDA IND-BB 10091; NCT 02046174, NCT 01053013). Barry H Smith, Lawrence S Gazda, +11 authors, David J Wolf. less Chin J Cancer Res, 2018 Mar 17; 30(1). PMID: 29545721 Free PMC article.
Chronic Medical Conditions and CA125 Levels among Women without Ovarian Cancer. Babatunde O Akinwunmi, Ana Babic, +4 authors, Kathryn L Terry. less Cancer Epidemiol Biomarkers Prev, 2018 Sep 22; 27(12). PMID: 30237250 Free PMC article.
Development and validation a simple model for identify malignant ascites. Ying-Yun Guo, Xiu-Lan Peng, +3 authors, Na Zhan, Shan Tian, Jiao Li, Wei-Guo Dong. less Int J Med Sci, 2021 Apr 15; 18(9). PMID: 33850466 Free PMC article.
Early Postnatal Comprehensive Biomarkers Cannot Identify Extremely Preterm Infants at Risk of Developing Necrotizing Enterocolitis. Alice Hoffsten, Laszlo Markasz, +2 authors, Richard Sindelar. less Front Pediatr, 2021 Nov 09; 9. PMID: 34746064 Free PMC article.

BioKDE: Biomedical Knowledge Discovery Engine

Abstract

Other Links